These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

609 related items for PubMed ID: 25453585

  • 21. Comparison of cycle control and side effects between transdermal contraceptive patch and an oral contraceptive in women older than 35 years.
    Boonyarangkul A, Taneepanichskul S.
    J Med Assoc Thai; 2007 Sep; 90(9):1715-9. PubMed ID: 17957909
    [Abstract] [Full Text] [Related]

  • 22. Oestrogen treatment for increased bleeding in Norplant users: preliminary results.
    Witjaksono J, Lau TM, Affandi B, Rogers PA.
    Hum Reprod; 1996 Oct; 11 Suppl 2():109-14. PubMed ID: 8982752
    [Abstract] [Full Text] [Related]

  • 23. Efficacy of combined hormonal vaginal ring in comparison to combined hormonal pills in heavy menstrual bleeding.
    Dahiya P, Dalal M, Yadav A, Dahiya K, Jain S, Silan V.
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():147-51. PubMed ID: 27285306
    [Abstract] [Full Text] [Related]

  • 24. Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 microg ethinylestradiol and 150 microg levonorgestrel: a randomized trial.
    Oddsson K, Leifels-Fischer B, Wiel-Masson D, de Melo NR, Benedetto C, Verhoeven CH, Dieben TO.
    Hum Reprod; 2005 Feb; 20(2):557-62. PubMed ID: 15539438
    [Abstract] [Full Text] [Related]

  • 25. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
    Kirkman RJ, Bromham DR, O'Connor TP, Sahota JE.
    Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
    [Abstract] [Full Text] [Related]

  • 26. Ethinylestradiol + norelgestromin: new preparation. Transdermal contraception: no tangible progress.
    Prescrire Int; 2004 Aug; 13(72):123-6. PubMed ID: 15532134
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial.
    Teichmann A, Apter D, Emerich J, Greven K, Klasa-Mazurkiewicz D, Melis GB, Spaczynski M, Grubb GS, Constantine GD, Spielmann D.
    Contraception; 2009 Dec; 80(6):504-11. PubMed ID: 19913143
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Open prospective multicenter trial with a new monophasic contraceptive combination containing gestodene.
    Renier M, Buytaert P.
    Contraception; 1991 May; 43(5):413-21. PubMed ID: 1914456
    [Abstract] [Full Text] [Related]

  • 32. Change to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunction.
    Davis SR, Bitzer J, Giraldi A, Palacios S, Parke S, Serrani M, Mellinger U, Nappi RE.
    J Sex Med; 2013 Dec; 10(12):3069-79. PubMed ID: 24034466
    [Abstract] [Full Text] [Related]

  • 33. Therapeutically equivalent pharmacokinetic profile across three application sites for AG200-15, a novel low-estrogen dose contraceptive patch.
    Stanczyk FZ, Archer DF, Rubin A, Foegh M.
    Contraception; 2013 Jun; 87(6):744-9. PubMed ID: 23228503
    [Abstract] [Full Text] [Related]

  • 34. Body mass index does not affect the efficacy or bleeding profile during use of an ultra-low-dose combined oral contraceptive.
    Nakajima ST, Pappadakis J, Archer DF.
    Contraception; 2016 Jan; 93(1):52-7. PubMed ID: 26410176
    [Abstract] [Full Text] [Related]

  • 35. New contraceptive patch wearability assessed by investigators and participants in a randomized phase 3 study.
    Kaunitz AM, Portman D, Westhoff CL, Mishell DR, Archer DF, Foegh M.
    Contraception; 2015 Mar; 91(3):211-6. PubMed ID: 25586864
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Comparison of two monophasic oral contraceptives: gestodene/ethinyl estradiol versus desogestrel/ethinyl estradiol.
    Benagiano G.
    Int J Fertil; 1989 Sep; 34 Suppl():31-9. PubMed ID: 2576255
    [Abstract] [Full Text] [Related]

  • 38. Pooled analysis of two randomized, open-label studies comparing the effects of nomegestrol acetate/17β-estradiol and drospirenone/ethinyl estradiol on bleeding patterns in healthy women.
    Mansour D, Westhoff C, Kher U, Korver T.
    Contraception; 2017 Apr; 95(4):390-397. PubMed ID: 28011288
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Multicenter, comparative study of cycle control, efficacy and tolerability of two low-dose oral contraceptives containing 20 microg ethinylestradiol/100 microg levonorgestrel and 20 microg ethinylestradiol/500 microg norethisterone.
    Endrikat J, Hite R, Bannemerschult R, Gerlinger C, Schmidt W.
    Contraception; 2001 Jul; 64(1):3-10. PubMed ID: 11535206
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.